<

 
Data updated 2025-04-28 00:05:00
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date15817678.4 (espacenet)  (Federated)  (European Patent Register), 20151209
Patent/reg. no. and dateDK/EP 3233108, 20220330
Publication date20171025
Priority no. and dateUS 201462092407 P, 20141216
EP pub. no. and date EP 3233108 20171025
Effective date
Applicant/ownerEli Lilly and Company, Lilly Corporate Center
Indianapolis, IN 46285, US
Applicant ref. no.V439420DK00
InventorAKERS, Michael Patrick, c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288, US,
MAJUMDAR, Ranajoy, c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288, US,
NGUYEN, Chi A., c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288, US,
PAAVOLA, Chad D., c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288, US,
SARIN, Virender Kumar, c/o Eli Lilly and Company
P. O. Box 6288
Indianapolis, Indiana 46206-6288, US,
SCHULTE, Nanette Elizabeth, c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis, Indiana 46206-6228, US
RepresentativeZacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S
Opponent
IPC ClassA61K 38/28 (2006.01) , A61K 47/12 (2006.01) , A61P 3/10 (2006.01) 
TitleHurtigtvirkende insulinsammensætninger
Int. application no.US2015064744
Int. publication no.WO2016100042
Related patent (certificate)
StatusDK/EP patent
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact